Frontiers | Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Rat RANkL ELISA Kit (RTES00706)- High Sensitivity
Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Ligand and G-protein selectivity in the κ-opioid receptor | Nature
Roles of receptor activator of nuclear factor κ B ligand (RANKL),... | Download Scientific Diagram
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Activation of osteoclasts by receptor activator of nuclear factor... | Download Scientific Diagram
Differential Patterns of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin Expression in Human Periapical Granulomas: Possible Association with Progressive or Stable Nature of the Lesions - ScienceDirect
coordination chemistry
Human Receptor Activator Of Nuclear Factor Kappa B Ligand ELISA Kit – Innovative Research
IJMS | Free Full-Text | Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2